EMSHF yields 2.69% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, EMSHF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EMSHF + MRK for your $10,000?
Ems-Chemie Holding AG engages in the high performance polymers and specialty chemicals businesses worldwide. The company's High Performance Polymers segment is involved in the manufacture and supply of high-performance polyamides granulates. Its Specialty Chemicals segment develops, produces, and sells fibers, bonding agent for tires, fusible adhesives, and adhesive yarns for technical and textile applications; powder coatings; and reactive diluents. The company also offers bonding, coating, sealing, and damping systems; and hotmelt adhesives, crosslinkers, epoxy systems, technical fibers, adhesion promoters, and fusible bonding yarns and granules. It serves automotive, electro and electronic, industry and consumer goods, optic, and packaging markets. The company was founded in 1936 and is based in Domat/Ems, Switzerland. EMS-CHEMIE HOLDING AG is a subsidiary of EMESTA HOLDING AG.
Full EMSHF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.